BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1969244)

  • 21. Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
    Lerner V; Miodownik C; Kaptsan A; Cohen H; Matar M; Loewenthal U; Kotler M
    Am J Psychiatry; 2001 Sep; 158(9):1511-4. PubMed ID: 11532741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
    Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
    Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baclofen in tardive dyskinesia patients maintained on neuroleptics.
    Stewart RM; Rollins J; Beckham B; Roffman M
    Clin Neuropharmacol; 1982 Dec; 5(4):365-73. PubMed ID: 6130838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
    Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia.
    Browne J; Silver H; Martin R; Hart R; Mergener M; Williams P
    J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
    Morselli PL; Fournier V; Bossi L; Musch B
    Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clonazepam in the treatment of tardive dyskinesia].
    Alecu C; Mărcuţiu V; Pruskauer-Apostol B; Voiculescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(4):285-9. PubMed ID: 6241738
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
    Dabiri LM; Pasta D; Darby JK; Mosbacher D
    Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in tardive dyskinesia after muscimol therapy.
    Tamminga CA; Crayton JW; Chase TN
    Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
    J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone-induced tardive dyskinesia.
    Bassitt DP; de Souza Lobo Garcia L
    Pharmacopsychiatry; 2000 Jul; 33(4):155-6. PubMed ID: 10958268
    [No Abstract]   [Full Text] [Related]  

  • 34. Diazepam in tardive dyskinesia.
    Weber SS; Dufresne RL; Becker RE; Mastrati P
    Drug Intell Clin Pharm; 1983; 17(7-8):523-7. PubMed ID: 6135591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is melatonin treatment effective for tardive dyskinesia?
    Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
    J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
    Ziegler M; Fournier V; Bathien N; Morselli PL; Rondot P
    Clin Neuropharmacol; 1987 Jun; 10(3):238-46. PubMed ID: 2900682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
    Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J
    Encephale; 1982; 8(3):371-6. PubMed ID: 6137357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
    Bouckaert F; Herman G; Peuskens J
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.